eMedicine Specialties > Cardiology > Myocardial Disease and Cardiomyopathies

Cardiomyopathy, Restrictive: Differential Diagnoses & Workup

Author: Vivek J Goswami, MD, Cardiologist, Austin Heart, PA
Contributor Information and Disclosures

Updated: Oct 9, 2008

Differential Diagnoses

Aortic Stenosis
Cardiac Tamponade
Cardiomyopathy, Hypertrophic
Hypertensive Heart Disease

Other Problems to Be Considered

All causes of diastolic dysfunction are included in the differential diagnosis.

Constrictive pericarditis is the most important disease to consider, since it is potentially curable. The physical findings of constriction and restriction are similar and may be confusing to the less-experienced clinician.

Systemic hypertension, valvular aortic stenosis, and hypertrophic cardiomyopathy all cause impaired diastolic distensibility secondary to left ventricular hypertrophy (LVH). The thickened LV could be confused with amyloidosis on echocardiography, but the clinical findings are completely different.

Workup

Laboratory Studies

Laboratory studies are performed to establish the diagnosis of restrictive cardiomyopathy, to quantitate the severity of the disease, and to monitor the patient.

  • Complete blood count with peripheral smear helps establish eosinophilia.
  • Blood gas analysis is performed to monitor hypoxia.
  • Obtain serum electrolytes, BUN and creatinine, and a liver function profile.
  • Serum iron concentrations, percent saturation of total iron-binding capacity, and serum ferritin levels are all increased in hemochromatosis.
  • Serum brain natriuretic peptide (BNP) level: Recent data suggest that serum BNP levels are nearly normal in patients with constrictive physiology of heart failure and grossly elevated in patients with restrictive physiology, despite nearly identical clinical and hemodynamic presentation.1

Imaging Studies

  • Chest radiograph: This typically shows cardiomegaly with bilateral pleural effusions.
  • Two-dimensional echocardiography
    • This shows a nondilated, normally contracting, nonhypertrophied left ventricle and marked dilatation of both atria. However, amyloidosis typically shows diffuse increased LV thickening.
    • The ventricular cavity size may be normal or reduced. The wall thickness may be increased in patients with infiltrative diseases. Mural thrombus and cavity obliteration are features of obliterative cardiomyopathy. In contrast, dilated cardiomyopathy shows dilatation of all the chambers of the heart, and increased wall thickness, especially of the ventricular septum, is observed in hypertrophic cardiomyopathy.
    • Abnormal myocardial textures can also be appreciated using echocardiography. For example, granular speckling of the ventricular walls suggests the presence of infiltrative disease, such as amyloidosis.
    • Pericardial thickening is not reliably observed on echocardiography; MRI is suggested for exclusion of a thick pericardium.
  • Doppler echocardiography
    • Doppler echocardiogram shows features of restriction to diastolic filling. Accentuated early diastolic filling of the ventricles (E), shortened deceleration time, and diminished atrial filling (A), which results in a high E-to-A ratio on the mitral inflow velocities, are present.
    • Variations of this diastolic (transmitral) blood flow with respiration help to differentiate between constrictive pericarditis and restrictive cardiomyopathy (RCM).
    • Because both of the ventricles are encased in a common constricting pericardial sac, an inspiratory increase in inflow to the right ventricle causes a reciprocal reduction in the transmitral inflow to the left ventricle. Thus, a pattern of respiratory variation, with a diminished peak transmitral diastolic flow during inspiration, is characteristic of pericardial constriction but not of myocardial restriction.
    • In contrast, in RCM, the left-sided filling pressures are elevated further in inspiration.
  • Tissue Doppler imaging: The use of pulsed-wave Doppler imaging is used in some centers as a noninvasive approach to distinguishing RCM and constrictive pericarditis. In addition to the information obtained by Doppler imaging, pulsed-wave Doppler imaging can define myocardial contraction and relaxation. This results in a measure referred to as the myocardial velocity gradient. Small studies have suggested that the myocardial velocity gradient is a specific measure that distinguishes these 2 entities well.
  • Cardiac catheterization
    • Ventricular pressure tracings of increased right heart pressures, typical venous wave pattern, and the dip-plateau or square-root contour of the ventricular diastolic pressures (deep and rapid early decline in ventricular pressure at the onset of diastole, with a rapid rise to a plateau in early diastole) obtained by cardiac catheterization are the same in pericardial constriction and RCM. This dip and plateau or square-root sign of ventricular pressure is manifested in the atrial pressure tracing as a prominent descent followed by a rapid rise to a plateau.
    • A few criteria favor the pericardial disorder, as follows:
      • Equalization of left and right ventricular filling pressures, with a difference of no more than 5 mm Hg between the 2 sides
      • Right ventricular end-diastolic pressure (RVEDP) equal to or exceeding one third of the level of the right ventricular systolic pressure (RVSP)
      • RVSP lower than 50 mm Hg
      • Persistence of diastolic equalization of pressures under stress or exercise or fluid challenge
    • In RCM, variance between right and left ventricular diastolic pressures is more likely to be greater than 5 mm Hg, RVEDP is more likely to be less than one third the RVSP, and the ventricular systolic pressure is more likely to be higher than 50 mm Hg.
  • Radionuclide imaging: Radionuclide imaging shows increased diffuse uptake of technetium-99m (99m Tc) pyrophosphate and indium-111 (111 In) antimyosin in cardiac amyloidosis.
  • Angiography: Angiography may show a small, thick-walled cavity in eosinophilic endomyocardial disease, which may be distorted significantly by a mural thrombus.
  • Cardiovascular magnetic resonance (CMR): More recently, CMR has been used to assess abnormal myocardial interstitium. Preliminary reports suggest a characteristic pattern of global subendocardial late gadolinium enhancement coupled with abnormal myocardial and blood-pool gadolinium kinetics in RCM.

Table 2. Investigation of Constrictive Cardiomyopathy and Restrictive Cardiomyopathy

Open table in new window

Table
InvestigationConstrictive CardiomyopathyRestrictive Cardiomyopathy
Chest radiographPericardial calcificationAtrial dilatation causing increased cardiothoracic ratio, normal ventricular size
CT scan/MRIPericardial thickeningNo pericardial thickening
EchocardiographyNormal-sized ventricles and atria; pericardial thickening, pericardial effusion may be observedNondilated, normally contracting, nonhypertrophied ventricles and marked dilatation of both atria; speckled texture of myocardium in cases of amyloid infiltration of the heart
Doppler flow velocities on echocardiographyRespiratory changes (ie, decreased peak transmitral diastolic flow) during inspiration
Equalization of the right- and left-sided filling pressures
No respiratory changes
Greater elevation in the left-sided filling pressures
Catheterization hemodynamics:
1) RVSP
2) RVEDP–to–RVSP ratio
3) RVEDP/LVEDP* equalization

1) £ 50 mm Hg
2) ³ 0.33
3) £ 5 mm Hg difference

1) ³ 50 mm Hg
2) £ 0.33
3) ³ 5 mm Hg difference
Cardiac biopsyNormal myocardiumOften diagnostic, showing abnormal myocardium
InvestigationConstrictive CardiomyopathyRestrictive Cardiomyopathy
Chest radiographPericardial calcificationAtrial dilatation causing increased cardiothoracic ratio, normal ventricular size
CT scan/MRIPericardial thickeningNo pericardial thickening
EchocardiographyNormal-sized ventricles and atria; pericardial thickening, pericardial effusion may be observedNondilated, normally contracting, nonhypertrophied ventricles and marked dilatation of both atria; speckled texture of myocardium in cases of amyloid infiltration of the heart
Doppler flow velocities on echocardiographyRespiratory changes (ie, decreased peak transmitral diastolic flow) during inspiration
Equalization of the right- and left-sided filling pressures
No respiratory changes
Greater elevation in the left-sided filling pressures
Catheterization hemodynamics:
1) RVSP
2) RVEDP–to–RVSP ratio
3) RVEDP/LVEDP* equalization

1) £ 50 mm Hg
2) ³ 0.33
3) £ 5 mm Hg difference

1) ³ 50 mm Hg
2) £ 0.33
3) ³ 5 mm Hg difference
Cardiac biopsyNormal myocardiumOften diagnostic, showing abnormal myocardium

*Left ventricular end-diastolic pressure

Other Tests

Electrocardiography (ECG): The findings on ECG depend on the stage of the disease and the specific diagnosis. The ECG may be normal or just show some nonspecific ST-T wave changes, but rhythm disorders (notably atrial fibrillation) are common. Conduction abnormalities are uncommon in amyloidosis. Low QRS voltage is common in amyloidosis, out of proportion to the thick LV on echocardiography. A pseudo-infarct pattern is possible, secondary to myocardial infiltration and/or small vessel induced ischemia or infarction.

Procedures

  • Cardiac biopsy: Ventricular biopsy obtained from either the right or the left ventricle has proved useful in certain cases in establishing whether endocardial or myocardial disease is present. Growing experience in this technique indicates a high diagnostic yield in diseases that may present with restriction hemodynamics, when noninvasive studies have failed to establish a clear-cut diagnosis. Amyloidosis demonstrates apple-green birefringence, stained with Congo red, viewed under a polarizing microscope.
  • Liver biopsy is performed for diagnosis of hemochromatosis.
  • Fine-needle aspiration of abdominal fat is easier and safer than myocardial biopsy to determine amyloidosis.
  • Confirmation of the diagnosis of AL amyloidosis demands a search for a plasma cell dyscrasia.

More on Cardiomyopathy, Restrictive

Overview: Cardiomyopathy, Restrictive
Differential Diagnoses & Workup: Cardiomyopathy, Restrictive
Treatment & Medication: Cardiomyopathy, Restrictive
Follow-up: Cardiomyopathy, Restrictive
References

References

  1. Leya FS, Arab D, Joyal D, Shioura KM, Lewis BE, Steen LH, et al. The efficacy of brain natriuretic peptide levels in differentiating constrictive pericarditis from restrictive cardiomyopathy. J Am Coll Cardiol. Jun 7 2005;45(11):1900-2. [Medline].

  2. Applefeld MM, Wiernik PH. Cardiac disease after radiation therapy for Hodgkin's disease: analysis of 48 patients. Am J Cardiol. Jun 1983;51(10):1679-81. [Medline].

  3. Bonow RO, Udelson JE. Left ventricular diastolic dysfunction as a cause of congestive heart failure. Mechanisms and management. Ann Intern Med. Sep 15 1992;117(6):502-10. [Medline].

  4. Brosius FC 3rd, Waller BF, Roberts WC. Radiation heart disease. Analysis of 16 young (aged 15 to 33 years) necropsy patients who received over 3,500 rads to the heart. Am J Med. Mar 1981;70(3):519-30. [Medline].

  5. Burstow DJ, Tajik AJ, Bailey KR, et al. Two-dimensional echocardiographic findings in systemic sarcoidosis. Am J Cardiol. Feb 15 1989;63(7):478-82. [Medline].

  6. Falk RH, Comenzo RL, Skinner M. The systemic amyloidoses. N Engl J Med. Sep 25 1997;337(13):898-909. [Medline].

  7. Katritsis D, Wilmshurst PT, Wendon JA, et al. Primary restrictive cardiomyopathy: clinical and pathologic characteristics. J Am Coll Cardiol. Nov 1 1991;18(5):1230-5. [Medline].

  8. Klein AL, Cohen GI, Pietrolungo JF, et al. Differentiation of constrictive pericarditis from restrictive cardiomyopathy by Doppler transesophageal echocardiographic measurements of respiratory variations in pulmonary venous flow. J Am Coll Cardiol. Dec 1993;22(7):1935-43. [Medline].

  9. Klein AL, Hatle LK, Burstow DJ, et al. Doppler characterization of left ventricular diastolic function in cardiac amyloidosis. J Am Coll Cardiol. Apr 1989;13(5):1017-26. [Medline].

  10. Kushwaha SS, Fallon JT, Fuster V. Restrictive cardiomyopathy. N Engl J Med. Jan 23 1997;336(4):267-76. [Medline].

  11. Lewis AB. Clinical profile and outcome of restrictive cardiomyopathy in children. Am Heart J. Jun 1992;123(6):1589-93. [Medline].

  12. Miller S, Riessen R. [MR imaging in cardiomyopathies]. Rofo. Nov 2005;177(11):1497-505. [Medline].

  13. Rochitte CE, Tassi EM, Shiozaki AA. The emerging role of MRI in the diagnosis and management of cardiomyopathies. Curr Cardiol Rep. Feb 2006;8(1):44-52. [Medline].

  14. Shammas RL, Movahed A. Sarcoidosis of the heart. Clin Cardiol. Jun 1993;16(6):462-72. [Medline].

  15. Sharma OP, Maheshwari A, Thaker K. Myocardial sarcoidosis. Chest. Jan 1993;103(1):253-8. [Medline].

  16. Valantine HA, Appleton CP, Hatle LK, et al. A hemodynamic and Doppler echocardiographic study of ventricular function in long-term cardiac allograft recipients. Etiology and prognosis of restrictive-constrictive physiology. Circulation. Jan 1989;79(1):66-75. [Medline].

Further Reading

Keywords

restrictive cardiomyopathy, RCM, myocardium, Loeffler's endocarditis, chronic endomyocardial fibrosis, diastolic heart failure, primary amyloidosis, eosinophilic, hemochromatosis, glycogen storage disease

Contributor Information and Disclosures

Author

Vivek J Goswami, MD, Cardiologist, Austin Heart, PA
Vivek J Goswami, MD is a member of the following medical societies: American College of Cardiology, American College of Physicians-American Society of Internal Medicine, American Heart Association, American Medical Association, and Illinois State Medical Society
Disclosure: Nothing to disclose.

Medical Editor

Gary E Sander, MD, PhD, Professor, Department of Internal Medicine, Division of Cardiology, Tulane University Health Sciences Center
Gary E Sander, MD, PhD is a member of the following medical societies: Alpha Omega Alpha, American College of Cardiology, American College of Chest Physicians, American College of Physicians, American Federation for Medical Research, American Heart Association, American Society of Hypertension, Heart Failure Society of America, Louisiana State Medical Society, and Southern Society for Clinical Investigation
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Frank M Sheridan, MD, Cardiology, Providence Everett Medical Center
Frank M Sheridan, MD is a member of the following medical societies: American College of Cardiology, American Heart Association, and Society for Cardiac Angiography and Interventions
Disclosure: Nothing to disclose.

CME Editor

Amer Suleman, MD, Consultant in Electrophysiology and Cardiovascular Medicine, Department of Internal Medicine, Division of Cardiology, Medical City Dallas Hospital
Amer Suleman, MD is a member of the following medical societies: American College of Physicians, American Heart Association, American Institute of Stress, American Society of Hypertension, Federation of American Societies for Experimental Biology, Royal Society of Medicine, and Society of Cardiac Angiography and Interventions
Disclosure: Nothing to disclose.

Chief Editor

Patrice Delafontaine, MD, FACC, FAHA, FACP, FESC, Sidney W and Marilyn S Lassen Professor of Cardiovascular Medicine, Chief, Section of Cardiology, Director, Cardiovascular Center of Excellence, Tulane University; Professor of Physiology, Chair, Department of Medicine, Tulane University School of Medicine
Patrice Delafontaine, MD, FACC, FAHA, FACP, FESC is a member of the following medical societies: Alpha Omega Alpha, American Association for the Advancement of Science, American College of Cardiology, American College of Physicians, American Diabetes Association, American Federation for Clinical Research, American Federation for Medical Research, American Heart Association, American Medical Association, American Society for Clinical Investigation, Association of American Physicians, Association of Professors of Cardiology, Association of Professors of Medicine, Endocrine Society, European Society of Cardiology, Louisiana State Medical Society, and Southern Society for Clinical Investigation
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.